(Q48234363)

9 February 2018

title

A new role for astrocytes: beta-amyloid homeostasis and degradation (English)

1 reference

9 February 2018

0 references

James A R Nicoll

1 reference

9 February 2018

Roy O Weller

series ordinal

1 reference

9 February 2018

publication date

1 July 2003

1 reference

9 February 2018

Trends in Molecular Medicine

published in

1 reference

9 February 2018

volume

1 reference

9 February 2018

issue

1 reference

9 February 2018

page(s)

281-282

1 reference

9 February 2018

Alzheimer's disease: genes, proteins, and therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900109-6

7 January 2021

Adult mouse astrocytes degrade amyloid-beta in vitro and in situ

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900109-6

7 January 2021

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900109-6

7 January 2021

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900109-6

7 January 2021

Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900109-6

7 January 2021

Biogenesis and metabolism of Alzheimer's disease Abeta amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900109-6

7 January 2021

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900109-6

7 January 2021

Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900109-6

7 January 2021

Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900109-6

7 January 2021

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900109-6

7 January 2021

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900109-6

7 January 2021

10.1016/S1471-4914(03)00109-6

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018